HomeSGMT • NASDAQ
Sagimet Biosciences Inc
add
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 18.20M | 92.21% |
Net income | -16.20M | -98.76% |
Net profit margin | — | — |
Earnings per share | -0.50 | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 151.25M | 59.38% |
Total assets | 160.26M | 65.70% |
Total liabilities | 4.45M | -21.22% |
Total equity | 155.81M | — |
Shares outstanding | 32.20M | — |
Price to book | 0.78 | — |
Return on assets | -27.15% | — |
Return on capital | -27.85% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -16.20M | -98.76% |
Cash from operations | -11.02M | -55.64% |
Cash from investing | 9.85M | 150.20% |
Cash from financing | 0.00 | — |
Net change in cash | -1.17M | 95.60% |
Free cash flow | -6.26M | -32.10% |
Previous close
$3.76
Day range
$3.61 - $3.93
Year range
$2.39 - $7.38
Market cap
118.16M USD
Avg Volume
423.61K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2006
Headquarters
Website
Employees
14
